Janet Liang Sells 10,360 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) insider Janet Liang sold 10,360 shares of the stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $325,822.00. Following the transaction, the insider directly owned 248,697 shares of the company’s stock, valued at $7,821,520.65. This trade represents a 4.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Down 4.1%

OSCR stock opened at $31.64 on Thursday. The company has a market cap of $9.77 billion, a price-to-earnings ratio of 22.60, a P/E/G ratio of 0.68 and a beta of 2.37. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $33.55. The business has a 50 day moving average price of $30.58 and a two-hundred day moving average price of $23.14. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The company had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. During the same quarter in the prior year, the business posted ($0.89) EPS. The business’s revenue was up 70.4% compared to the same quarter last year. Analysts anticipate that Oscar Health, Inc. will post 1.54 EPS for the current fiscal year.

Key Oscar Health News

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: A recent outlook article argues that Oscar Health’s future remains bright, supported by its technology-driven insurance platform, expanding membership opportunities and potential for continued earnings growth. The future looks bright for Oscar Health stock
• Positive Sentiment: The company’s latest quarterly results were substantially better than expected: earnings per share came in at $1.10 versus the $0.40 consensus estimate, while revenue rose 70.4% year over year to $4.88 billion. Analysts expect full-year EPS of approximately $1.54.
• Positive Sentiment: Institutional ownership remains high at approximately 75.7%, and several funds increased their Oscar Health holdings during the second quarter. Analyst sentiment has also improved in some cases, including a Zacks Research upgrade to “strong buy.”
• Neutral Sentiment: Oscar Health’s chief accounting officer Victoria Baltrus sold 958 shares for $30,129 under a pre-arranged Rule 10b5-1 plan. The filing said the sale covered tax withholding tied to vested equity awards; she retained 213,631 shares. Oscar Health CAO stock sale
• Neutral Sentiment: Director Mario Schlosser, CFO Richard Blackley, Adam Mcananey and Janet Liang also reported stock sales totaling roughly $2.5 million. Each transaction was conducted under a 10b5-1 plan and attributed to tax obligations, while all sellers retained sizable positions.
• Negative Sentiment: The cluster of insider selling may nevertheless weigh on sentiment, particularly because the transactions occurred near OSCR’s 52-week high. The stock’s average analyst rating remains “hold,” with a consensus price target of $26.22, below recent trading levels.

Analyst Ratings Changes

A number of research analysts have recently commented on OSCR shares. UBS Group lifted their price objective on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a research report on Friday, August 7th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $30.00 target price on shares of Oscar Health in a research note on Tuesday, August 11th. Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Robert W. Baird set a $27.00 price objective on Oscar Health in a research report on Friday, August 7th. Finally, Weiss Ratings upgraded Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $26.22.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds have recently bought and sold shares of the business. Thrive Capital Management LLC raised its stake in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after purchasing an additional 1,588,395 shares in the last quarter. Baird Financial Group Inc. bought a new position in shares of Oscar Health during the first quarter worth approximately $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Oscar Health by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock worth $2,827,000 after purchasing an additional 8,879 shares during the period. Jones Financial Companies Lllp raised its position in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Oscar Health by 39.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock valued at $6,169,000 after buying an additional 132,149 shares in the last quarter. 75.70% of the stock is owned by institutional investors.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.